Development of experimental carbohydrate-conjugate vaccines composed of Streptococcus pneumoniae capsular polysaccharides and the universal helper T-lymphocyte epitope (PADRE®)
- 1 June 2004
- Vol. 22 (19) , 2362-2367
- https://doi.org/10.1016/j.vaccine.2003.11.061
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Protection against Streptococcus pneumoniae Elicited by Immunization with Pneumolysin and CbpAInfection and Immunity, 2001
- Pneumococcal serotypes and their clinical relevanceThorax, 1998
- Immunization with a plasmid expressing pneumococcal surface protein A (PspA) can elicit protection against fatal infection with Streptococcus pneumoniaeGene Therapy, 1997
- Effect of conjugation methodology, carrier protein, and adjuvants on the immune response to Staphylococcus aureus capsular polysaccharidesVaccine, 1995
- Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptidesImmunity, 1994
- Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 moleculesCell, 1993
- Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus.Journal of Clinical Investigation, 1990
- Some Observations on the Pneumococcus and on the Current Status of Pneumococcal Disease and Its PreventionClinical Infectious Diseases, 1981
- Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates.The Journal of Experimental Medicine, 1980
- Prevention of Pneumococcal Infection by Immunization with Capsular Polysaccharides of Streptococcus pneumoniae: Current Status of Polyvalent VaccinesThe Journal of Infectious Diseases, 1977